PET Imaging of the Dopamine Transporter with 11C-WIN 35, 428 Reveals Marked Declines in Mild Parkinson's Disease
Ann Neurol 34:423-431, Frost,J.J.,et al, 1993
Attitudes Toward Direct Predictive Testing for the Huntington Disease Gene
JAMA 270:2321-2325, Babul,R.,et al, 1993
Cranial Neuropathy Heralding Otherwise Occult AIDS-Related Large Cell Lymphoma
J Clin Neuro-Ophthalmol 13:113-118, Berger,J.R.,et al, 1993
Multiple Sclerosis:The Impact of MR Imaging
AJR 158:849-857, Wallace,C.J.,et al, 1992
Presymptomatic Testing for Huntington's Disease in the United Kingdom
BMJ 304:1593-1596, Tyler,A.,et al, 1992
Gadolinium-Pentetic Acis Magnetic Resonance Imaging in Patients with Relapsing Remitting Multiple Sclerosis
Arch Neurol 49:687-689, Capra,R.,et al, 1992
The Psychological Consequences of Predictive Testing for Huntington's Disease
NEJM 327:1401-1405, 14491992., Wiggins,S.,et al, 1992
Familial Multiple Sclerosis:MRI Findings in Clinically Affected and Unaffected Siblings
JNNP 55:883-886, Teinari,P.J.,et al, 1992
Lidocaine Unmasks Silent Demyelinative Lesions in Multiple Sclerosis
Neurol 42:2088-2093, Sakurai,M.,et al, 1992
Serial Changes of Cerebral Glucose Metab & Caudate Size in Persons at Risk for Huntington's Dis
Arch Neurol 49:1161-1167, Grafton,S.T.,et al, 1992
Neurogenic Dysphagia Resulting from Chiari Malformations
Neurosurg 30:709-719, Pollack,IF,et al, 1992
Young-Onset Parkinson's Disease:A Clinical Review
Neurol 41:168-173, Golbe,L.I., 1991
Preclinical Detection of Parkinson's Disease
Neurology Suppl 2, 41:5-921991., Koller,W.C.&Langston,J.W., 1991
MR of the Head in Diagnosis of MS:A Prospective 2-yr Follow-up with Clinical Eval, Evoked Pot, Oligoclonal Banding, & CT
Neurol 41:657-660, Lee,K.H.,et al, 1991
Serum Antibodies to GM1 and GM3-gangliosides in Systemic Lupus Erythematosus with Chronic Inflammatory Demyelinating Polyradiculoneuropathy
Acta Neurol Scand 83:399-402, Sindern,E.,et al, 1991
Clinical Signs in Severe Guillain-Barre Syndrome: Analysis of 63 Patients
J Neurol Sci 104:143-150, De Jager, A.E.J.,et al, 1991
Genetic Testing for Huntington's Disease
BMJ 300:1089-1090, Harper,P.,et al, 1990
Abnormalities of Striatal Projection Neurons and n-Methyl-d-Aspartate Receptors in Presymptomatic Huntington's Disease
NEJM 322:1293-1298, Albin,R.L.,et al, 1990
Ptosis as the Sole Manifestation of Compression of the Oculomotor Nerve by an Aneurysm of the Posterior Communicating Artery
J Clin Neuroophthalmol 10:59-61, Good,E.F., 1990
Creutzfeldt-Jakob Disease Presenting as Isolated Aphasia
Neurol 39:55-58, Mandell,A.M.,et al, 1989
Predictive Testing for Huntington's Disease with Linked DNA Markers
Lancet 2:463-466, Brock,D.J.H.,et al, 1989
Problems in Genetic Prediction for Huntington's Disease
Lancet 2:601-603, Morris,M.J.,et al, 1989
Uptake of Presymptomatic Predictive Testing for Huntington's Disease
Lancet 2:603-605, Craufurd,D.,et al, 1989
Predictive Testing for Huntington's Disease, Progress and Problems
BMJ 298:404-405, 1989, Harper,P.S.&Morris,M.J., 1989
Sudden Sensorineural Hearing Loss as a Presentation of HIV infection
J Laryngol Otol 103:1071-1072, Timon, C.I. & Walsh, M.A., 1989
New-Onset Seizures Associated with Human Immunodeficiency Virus Infection: Causation and Clinical Features in 100 Cases
Am J Med 87:173-177, Holtzman, D.M.,et al, 1989
Ischemic Stroke as the Presenting Manifestation of Localized Systemic Cancer
Schweiz Arch Neurol Psychiatr 139:5-11, 1988, Cornuz, J. & Bogousslavsky,C.J.,et al, 1988
Adoption and Genetic Prediction for Huntington's Disease
Lancet 2:1069-1070, Morris,M.,et al, 1988
Predictive Testing for Huntington's Disease with Use of a Linked DNA Marker
NEJM 318:535-542, Meissen,G.J.,et al, 1988
Presymptomatic Neuropsychological Impairment in Huntington's Disease
Arch Neurol 45:769-773, Jason,G.W.,et al, 1988
Normal Caudate Glucose Metabolism in Persons at Risk for Huntington's Disease
Arch Neurol 44:254-257, Young,A.B.,et al, 1987
Reduced Cerebral Glucose Metabolism in Asymptomatic Subjects at Risk for Huntington's Disease
NEJM 316:357-362, Mazziotta,J.C.,et al, 1987
The Combined Use of Positron Emission Tomography & DNA Polymorphisms for Preclinical Detection of Huntington's Disease
Neurol 37:1441-1447, Hayden,M.R.,et al, 1987
Neurologic Disease as the Presenting Manifestation of Acquired Immunodefieicney Syndrome
South Med J 80:683-686, Berger,J.R.,et al, 1987
Positron Emission Tomography in the Early Diagnosis of Huntington's Disease
Neurol 36:888-894, Hayden,M.R.,et al, 1986
Huntington's Disease, Pathogenesis & Management
NEJM 315:1267-1276, Martin,J.B.&Gusella,J.F., 1986
Presymptomatic Testing for Huntington's Disease
JAMA 253:3286-3291, Bird,S.J., 1985
Genetic Prediction & Family Structure in Huntington's Chorea
BMJ 290:1929-1931, Harper,P.S.,et al, 1985
A DNA Polymorphism for Huntington's Disease Marks the Future
Arch Neurol 42:20-24, Wexler,N.S.,et al, 1985
Genetic Testing in Huntington's Disease
Ann Neurol 16:511-513, Koller,W.C.,et al, 1984
Unsuspected Multiple Sclerosis
Arch Neurol 40:533-536, Gilbert,J.J.,et al, 1983
A Genetic Marker for Huntington's Chorea
BMJ 287:1567-1568, Harper,P.S., 1983
False-Negative Results With Levodopa For Early Detection Of Huntington's Disease
NEJM 307:561-562, Myers,R.H.,et al, 1982
Attitudes Of Those At Risk For Huntington's Disease Toward Presymptomatic Provocative Testing
NEJM 307:1406, McCormack,M.K., 1982
Levodopa & Presymptomatic Detection of Huntington's Disease-Eight-Year Follow-Up
NEJM 302:1090, Klawans,H.L.,et al, 1980
Presymptomatic & Early Detection in Huntington's Disease
Ann Neurol 8:343-347, Klawans,H.L.,et al, 1980
Huntington's Disease, CSF GABA Level in at-risk Individuals
Arch Neurol 35:728-730, Manyam,N.V.B.,et al, 1978
Recurrent Aseptic Meningitis in an Elderly Male, Unusual Prodromal Manifestation of SLE
JAMA 235:1142, Finelli,P.F.,et al, 1975
Use of L-Dopa in the Detection of Presymptomatic Huntington's Chorea
NEJM 286:1332, Klawans,H.,et al, 1972
Presymptomatic Detection of Huntington's Chorea
BMJ 540, 1972 Sept., , 1972